Total Payments
$1,926
2024 Payments
$309.05
Companies
14
Transactions
111
Medicare Patients
908
Medicare Billing
$398,880

Payment Breakdown by Category

Food & Beverage$1,632 (84.7%)
Education$270.97 (14.1%)
Other$22.97 (1.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,632 106 84.7%
Education $270.97 4 14.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22.97 1 1.2%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $751.72 64 $0 (2024)
Celgene Corporation $293.06 18 $0 (2023)
Teva Pharmaceuticals USA, Inc. $282.89 7 $0 (2022)
Amgen Inc. $200.16 4 $0 (2019)
Allergan, Inc. $191.94 8 $0 (2021)
Lilly USA, LLC $43.93 2 $0 (2024)
Sunovion Pharmaceuticals Inc. $27.04 1 $0 (2020)
Roche Diagnostics Corporation $24.00 1 $0 (2017)
Acorda Therapeutics, Inc $22.97 1 $0 (2019)
Supernus Pharmaceuticals, Inc. $22.50 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $309.05 21 ABBVIE INC. ($281.25)
2023 $42.12 3 Celgene Corporation ($28.67)
2022 $518.66 33 ABBVIE INC. ($280.64)
2021 $320.24 30 AbbVie Inc. ($176.38)
2020 $39.04 2 Sunovion Pharmaceuticals Inc. ($27.04)
2019 $155.26 4 Amgen Inc. ($91.32)
2018 $168.16 6 Amgen Inc. ($108.84)
2017 $373.34 12 Teva Pharmaceuticals USA, Inc. ($212.90)

All Payment Transactions

111 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/19/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $7.56 General
Category: BOTOX THERAPEUTIC
12/12/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $22.97 General
Category: BOTOX THERAPEUTIC
12/10/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $11.24 General
Category: NEUROSCIENCE
11/07/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $9.76 General
Category: NEUROSCIENCE
11/07/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $3.56 General
Category: NEUROSCIENCE
10/29/2024 ABBVIE INC. VYALEV (Drug) Food and Beverage In-kind items and services $21.31 General
Category: NEUROSCIENCE
10/03/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $78.12 General
Category: NEUROSCIENCE
09/30/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $7.15 General
Category: NEUROSCIENCE
09/26/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $7.06 General
Category: BOTOX THERAPEUTIC
09/19/2024 Lilly USA, LLC Food and Beverage In-kind items and services $27.80 General
09/17/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $3.14 General
Category: BOTOX THERAPEUTIC
08/14/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $4.56 General
Category: NEUROSCIENCE
07/24/2024 ABBVIE INC. QULIPTA (Drug), BOTOX Food and Beverage In-kind items and services $3.52 General
Category: NEUROSCIENCE
06/27/2024 ABBVIE INC. UBRELVY (Drug), BOTOX Food and Beverage In-kind items and services $10.78 General
Category: NEUROSCIENCE
05/10/2024 ABBVIE INC. UBRELVY (Drug), BOTOX Food and Beverage In-kind items and services $7.61 General
Category: NEUROSCIENCE
05/10/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $2.05 General
Category: NEUROSCIENCE
05/03/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $20.09 General
Category: BOTOX THERAPEUTIC
04/19/2024 ABBVIE INC. UBRELVY (Drug), BOTOX Food and Beverage In-kind items and services $9.21 General
Category: NEUROSCIENCE
04/04/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $15.73 General
Category: NEUROSCIENCE
03/20/2024 ABBVIE INC. DUOPA (Drug) Food and Beverage In-kind items and services $24.33 General
Category: NEUROSCIENCE
03/20/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $11.50 General
Category: NEUROSCIENCE
08/18/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $14.00 General
Category: Neuroscience
08/10/2023 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $13.45 General
Category: BOTOX THERAPEUTIC
06/14/2023 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $14.67 General
Category: Neuroscience
12/15/2022 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $6.68 General
Category: NEUROSCIENCE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 254 16,454 $197,965 $110,946
2022 9 245 16,009 $187,727 $102,939
2021 8 239 15,896 $188,904 $103,679
2020 7 170 13,915 $155,780 $81,317
Total Patients
908
Total Services
62,274
Medicare Billing
$398,880
Procedure Codes
33

All Medicare Procedures & Services

33 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
J0585 Injection, onabotulinumtoxina, 1 unit Office 2023 25 16,150 $124,249 $80,038 64.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 64 83 $20,750 $10,196 49.1%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2023 16 55 $16,500 $5,576 33.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 52 68 $11,900 $5,566 46.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 22 22 $6,600 $3,190 48.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 25 25 $6,826 $2,691 39.4%
95910 Nerve conduction, 7-8 studies Office 2023 16 16 $4,920 $2,038 41.4%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Office 2023 23 24 $4,920 $1,077 21.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 11 11 $1,300 $572.38 44.0%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2022 28 15,735 $121,197 $74,982 61.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 51 62 $15,500 $7,556 48.7%
64615 Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face Office 2022 19 58 $17,400 $6,087 35.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 51 56 $9,800 $4,565 46.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 33 33 $9,010 $3,805 42.2%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 13 13 $3,900 $2,068 53.0%
95910 Nerve conduction, 7-8 studies Office 2022 14 14 $4,200 $1,962 46.7%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Office 2022 25 27 $5,400 $1,354 25.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 11 11 $1,320 $561.07 42.5%
J0585 Injection, onabotulinumtoxina, 1 unit Office 2021 27 15,625 $120,345 $73,037 60.7%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 54 64 $16,000 $8,449 52.8%
64615 Injection of chemical for destruction of facial and neck nerve muscles on both sides of face Office 2021 20 61 $18,300 $6,727 36.8%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 33 33 $9,009 $4,078 45.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 39 46 $8,050 $3,863 48.0%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 21 21 $6,300 $3,655 58.0%
95910 Nerve transmission studies, 7-8 studies Office 2021 17 17 $5,100 $2,351 46.1%

About Dr. Ryan Evans, M.D

Dr. Ryan Evans, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245242981.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Evans, M.D has received a total of $1,926 in payments from pharmaceutical and medical device companies, with $309.05 received in 2024. These payments were reported across 111 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,632).

As a Medicare-enrolled provider, Evans has provided services to 908 Medicare beneficiaries, totaling 62,274 services with total Medicare billing of $398,880. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.

Practice Information

Products in Payments

  • UBRELVY (Drug) $348.37
  • ZEPOSIA (Drug) $305.06
  • BOTOX (Biological) $186.37
  • QULIPTA (Drug) $183.65
  • Aimovig (Biological) $183.62
  • COPAXONE (Drug) $141.84
  • BOTOX NEURO REHAB (Drug) $89.76
  • LINZESS (Drug) $75.99
  • KYNMOBI (Drug) $27.04
  • DUOPA (Drug) $24.33
  • RS Harmony Test Related Products (Device) $24.00
  • INBRIJA (Drug) $22.97
  • TROKENDI XR (Drug) $22.50
  • Trudhesa (Drug) $21.95
  • VYALEV (Drug) $21.31
  • Mavenclad (Biological) $18.47
  • EMGALITY (Drug) $16.13
  • NAMZARIC (Drug) $13.88
  • Dhivy (Drug) $13.24

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Rochester